[Parkinson's disease].
By Houeto Jean-Luc. La Revue du praticien, 2022
15,057 citations recorded by the source corpus.
View Paper: https://www.semanticscholar.org/paper/880ff9a2d1b63cc77e6fcf02a68a38ab8439bcc3
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Tao Wu
- Alicia M. Pickrell
- Wei Pan
- Jonathan E. Rubin
- Mark Hallett
- Kallol Ray Chaudhuri
- M. Farrer
- Michael G. Erkkinen
Citations in the corpus
- Psychological status of medical workforce during the COVID-19 pandemic: A cross-sectional study (2020, unknown): “Various of previous studies had shown that these questionnaires could assess psychological condition with satisfactory reliability and validity (Chen et al., 2020b; Zhang et al., 2020a).”
- Role of ROS and Nutritional Antioxidants in Human Diseases (2018, background): “Research has shown that 35% of cancer can be prevented by dietary modifications (Doll and Peto, 1981; Rayman, 2005).”
- Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases (2016, background): “Parkinson’s disease (PD) is the second most common neurodegenerative disease, affecting 1–2% of the elderly population (Lees et al., 2009).”
- Prevalence and incidence of Parkinson's disease in Europe. (2005, background): “Five studies could not be obtained as full articles (Briz, 1988; Dias, 1993; Lima, 1989; Ló pez, 1993; Manubens, 1993).”
- The cerebellum in Parkinson’s disease (2013, background): “In a study on motor urgency in Parkinson’s disease (Ballanger et al., 2008), during performance of externally cued movements in an urgent situation, the cerebellum was more activated in patients with Parkinson’s disease.”
- Stages in the development of Parkinson’s disease-related pathology (2004, background): “6; Lowe 1994; Braak et al. 1998; Takahashi and Wakabayashi 2001; Apaydin et al. 2002; Jellinger and Mizuno 2003).”
- The Roles of PINK1, Parkin and Mitochondrial Fidelity in Parkinson's Disease (2015, background): “Four cardinal signs characterize PD, rigidity, bradykinesia, postural instability, and tremor (Lang and Lozano, 1998a, 1998b), that stem from the progressive loss of dopaminergic neurons in the substantia nigra pars compacta (SN).”
- Caenorhabditis elegans: An Emerging Model in Biomedical and Environmental Toxicology (2008, background): “PD cases are referred as familial (FPD) or idiopathic (IPD) depending on whether the disease is hereditary (FPD) or from unknown origin, possibly due to environmental exposure to neurotoxicants (IPD) (Dauer and Przedborski, 2003; Samii et al., 2004).”
- Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease. (2014, background): “In addition, inclusions called Lewy bodies (LBs), which are composed of α-synuclein and ubiquitinated proteins, are found within the remaining SN neurons [247].”
- Mitochondrial Dysfunction in Parkinson's Disease (2011, background): “Parkinson’s disease (PD) is a progressive, neurodegenerative condition characterised by deterioration of the dopaminergic (DA) neurons of the substantia nigra pars compacta (SNpc) [1, 2].”